Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 30 resultados

SEARCH: Synthetic hEalthcare dAta goveRnanCe Hub TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un HORIZON EUROPE: HORIZON-JU-IHI-2023-05 The objectives of SEARCH are truly ground-breaking, seeking to enable extensive data aggregation and analysis while safeguarding the integri...
2024-09-13 - 2028-09-30 | Financiado

VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado

IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado

EPND: European platform for neurodegenerative disorders TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage Alzheimer’s disease (AD) and Parkinson’s disease (PD) are common neurodegenerative conditions, posing a major societal burden. There is a la...
2021-10-25 - 2026-10-31 | Financiado

SCREEN4CARE: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technol... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage In the EU alone, according to the Orphanet DB (https://pubmed.ncbi.nlm.nih.gov/31527858/), 30 million persons, 3,5-6% of the general populat...
2021-10-13 - 2026-09-30 | Financiado

FACILITATE: FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical eco... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage FACILITATE is a project built on a patient-centered, data-driven, technological platform where an innovative data sharing and re-use process...
2021-10-11 - 2025-12-31 | Financiado

BEAMER: BEhavioral and Adherence Model for improving quality health outcomes and cost Effectiveness of heal... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage The main objective of the Project is to create BEAMER, a disease-agnostic behavioral and adherence model for improving quality, health outco...
2021-09-27 - 2026-08-31 | Financiado

Inno4Vac: Innovations to accelerate vaccine development and manufacture TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado

T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative...
2020-11-24 - 2025-12-31 | Financiado

ARDAT: Accelerating Research Development for Advanced Therapies TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune...
2020-11-11 - 2025-10-31 | Financiado

COVID-RED: COVID 19 infections Remote Early Detection TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pu...
2020-10-16 - 2022-12-31 | Financiado

H2O: H2O Health Outcomes Observatory TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspectiv...
2020-09-30 - 2025-09-30 | Financiado

CARE: Corona Accelerated R D in Europe TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in thi...
2020-08-07 - 2025-03-31 | Financiado

IDEA-FAST: Identifying Digital Endpoints to Assess FAtigue Sleep and acTivities in daily living in Neurodegene... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Fatigue and sleep disturbances are two common and disabling symptoms that affect patients with neurodegenerative disorders (NDD) and immune-...
2019-12-18 - 2026-04-30 | Financiado

Immune-Image: Immune Image Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Immunotherapies have emerged as effective treatments for immune system-related diseases, such as cancer and inflammatory diseases. Although...
2019-09-26 - 2026-03-31 | Financiado

3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado

Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado

ConcePTION: Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and... TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about...
2019-05-06 - 2024-12-31 | Financiado

MOBILISE-D: Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage Optimal treatment of the impaired mobility resulting from ageing and chronic disease is one of the 21st century's greatest challenges facing...
2019-03-22 - 2024-06-30 | Financiado

EBiSC2: EBiSC2 A sustainable European Bank for induced pluripotent Stem Cells TAKEDA PHARMACEUTICALS INTERNATIONAL AG participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage EBiSC2 builds on the achievements of the European Bank for iPSCs (EBiSC1) in centralising existing capacities across Europe in a unique bank...
2019-02-28 - 2023-02-28 | Financiado

TPIZ